Compugen Ltd (NASDAQ: CGEN)’s stock price has increased by 3.52 compared to its previous closing price of 2.27. However, the company has seen a 17.50% increase in its stock price over the last five trading sessions. https://thefly.com reported 2025-01-13 that Compugen +0.05 (+3.14%) AstraZeneca +0.44 (+0.66%) Gilead +0.7 (+0.79%)
Is It Worth Investing in Compugen Ltd (NASDAQ: CGEN) Right Now?
Compugen Ltd (NASDAQ: CGEN) has a price-to-earnings ratio that is above its average at 122.40x. The stock has a 36-month beta value of 2.65. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CGEN is 84.72M, and at present, short sellers hold a 1.49% of that float. On January 22, 2025, the average trading volume of CGEN was 571.17K shares.
CGEN’s Market Performance
The stock of Compugen Ltd (CGEN) has seen a 17.50% increase in the past week, with a 55.63% rise in the past month, and a 37.43% gain in the past quarter. The volatility ratio for the week is 11.06%, and the volatility levels for the past 30 days are at 8.56% for CGEN. The simple moving average for the past 20 days is 32.21% for CGEN’s stock, with a 27.98% simple moving average for the past 200 days.
Analysts’ Opinion of CGEN
Many brokerage firms have already submitted their reports for CGEN stocks, with Oppenheimer repeating the rating for CGEN by listing it as a “Outperform.” The predicted price for CGEN in the upcoming period, according to Oppenheimer is $4 based on the research report published on January 13, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see CGEN reach a price target of $2. The rating they have provided for CGEN stocks is “Hold” according to the report published on August 05th, 2022.
JMP Securities gave a rating of “Mkt Outperform” to CGEN, setting the target price at $18 in the report published on May 26th of the previous year.
CGEN Trading at 42.58% from the 50-Day Moving Average
After a stumble in the market that brought CGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.44% of loss for the given period.
Volatility was left at 8.56%, however, over the last 30 days, the volatility rate increased by 11.06%, as shares surge +54.61% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.63% upper at present.
During the last 5 trading sessions, CGEN rose by +17.50%, which changed the moving average for the period of 200-days by +1.29% in comparison to the 20-day moving average, which settled at $1.78. In addition, Compugen Ltd saw 53.59% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CGEN
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.85 for the gross margin
The net margin for Compugen Ltd stands at 0.03. The total capital return value is set at 0.11. Equity return is now at value 2.81, with 1.67 for asset returns.
Currently, EBITDA for the company is -12.52 million with net debt to EBITDA at -0.4. When we switch over and look at the enterprise to sales, we see a ratio of 3.5. The receivables turnover for the company is 28.21for trailing twelve months and the total asset turnover is 0.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.14.
Conclusion
To sum up, Compugen Ltd (CGEN) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
